These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 237568)

  • 1. The effects of the trinitrophenylation of the amino groups of glucagon on its conformational properties and on its ability to activate rat liver adenylyl cyclase.
    Epand RM; Wheeler GE
    Biochim Biophys Acta; 1975 May; 393(1):236-46. PubMed ID: 237568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of specific trinitrophenylation of the lysine epsilon amino group of glucagon on receptor binding and adenylate cyclase activation.
    Liepnieks JJ; Epand RM
    Arch Biochem Biophys; 1983 Aug; 225(1):102-9. PubMed ID: 6311099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational and biological properties of a covalently linked dimer of glucagon. Reaction of mono- and bifunctional sulfenyl halides.
    Epand RM; Cote TE
    Biochim Biophys Acta; 1976 Dec; 453(2):365-73. PubMed ID: 999894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the conformational properties of glucagon in the presence of glycols.
    Contaxis CC; Epand RM
    Can J Biochem; 1974 Jun; 52(6):456-68. PubMed ID: 4844282
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of nonspecific hydrophobic interactions in the biological activity of N epsilon-acyl derivatives of glucagon. Studies of conformation, receptor binding, and adenylate cyclase activation.
    Carrey EA; Epand RM
    J Biol Chem; 1982 Sep; 257(18):10624-30. PubMed ID: 6286664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipolytic and adenyl-cyclase-stimulating activity of N alpha-trinitrophenyl glucagon: comparison with other glucagon derivatives modified at the amino terminus.
    Jean-Baptiste E; Rizack MA; Epand RM
    Biosci Rep; 1982 Mar; 2(3):163-7. PubMed ID: 7066487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation of predicted structure to observed conformation and activity of glucagon analogs containing replacements at positions 19, 22, and 23.
    Murphy J; Zhang WJ; Macaulay W; Fasman G; Merrifield RB
    J Biol Chem; 1987 Dec; 262(36):17304-12. PubMed ID: 3693354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of 2-thioltryptophan-glucagon and (tryptophan-S-glucagon)2. Differences in binding to the glucagon receptor in the hepatic adenylate cyclase system.
    Wright DE; Rodbell M
    J Biol Chem; 1980 Nov; 255(22):10884-7. PubMed ID: 7430160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of amidinated glucagons.
    Wright DE; Rodbell M
    Eur J Biochem; 1980 Oct; 111(1):11-6. PubMed ID: 7439177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.
    Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
    J Clin Invest; 1984 Apr; 73(4):1004-12. PubMed ID: 6323531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semisynthetic derivatives of glucagon. The contribution of histidine-1 to hormone conformation and activity.
    Flanders KC; Horwitz EM; Gurd RS
    J Biol Chem; 1984 Jun; 259(11):7031-7. PubMed ID: 6547139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon stimulation of adenylate cyclase sulfhydryl reactivity. Evidence for hormone-induced conformational changes.
    Storm DR; Dolginow YD
    J Biol Chem; 1973 Jul; 248(14):5208-10. PubMed ID: 4352196
    [No Abstract]   [Full Text] [Related]  

  • 13. Conformational changes of protected glucagon fragments bound to lysolecithin.
    Edelhoch H; Schneider AB
    Arch Biochem Biophys; 1973 Aug; 157(2):470-5. PubMed ID: 4738379
    [No Abstract]   [Full Text] [Related]  

  • 14. Simple model for hormone-activated adenylate cyclase systems.
    Hammes GG; Rodbell M
    Proc Natl Acad Sci U S A; 1976 Apr; 73(4):1189-92. PubMed ID: 4796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of glucagon action on the hepatic adenylate cyclase system.
    Rodbell M; Birnbaumer L; Pohl SL
    Biochem J; 1971 Dec; 125(3):58P-59P. PubMed ID: 5145874
    [No Abstract]   [Full Text] [Related]  

  • 16. Acetylglucagon: preparation and characterization.
    Desbuguois B
    Eur J Biochem; 1975 Dec; 60(2):335-47. PubMed ID: 1270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semisynthetic D-His1,N epsilon-acetimidoglucagon: structure-function relationships.
    Mahrenholz AM; Flanders KC; Hoosein NM; Gurd FR; Gurd RS
    Arch Biochem Biophys; 1987 Sep; 257(2):379-86. PubMed ID: 2821912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon amino groups. Evaluation of modifications leading to antagonism and agonism.
    Bregman MD; Trivedi D; Hruby VJ
    J Biol Chem; 1980 Dec; 255(24):11725-31. PubMed ID: 7440567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of glucagon, characterization of the sulfonium derivative, and regeneration of the native covalent structure.
    Rothgeb TM; Jones BN; Hayes DF; Gurd RS
    Biochemistry; 1977 Dec; 16(26):5813-8. PubMed ID: 588556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential acid stabilities of citraconylated amino groups of glucagon. Preparation of N alpha-citraconyl glucagon and evaluation of its biological properties.
    Liepnieks JJ; Epand RM
    Biochim Biophys Acta; 1982 Oct; 707(2):171-7. PubMed ID: 6291617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.